Investor events | Innate Pharma

Innate Pharma announces its financial calendar for 2015 as well as its participation in upcoming investor conferences

December 2, 2014

Innate Pharma SA (the “Company” - Euronext Paris: FR0010331421 – IPH), the innate immunity company developing first-in-class therapeutic antibodies for cancer and inflammatory diseases, announces...

Highlights from Innate Pharma's R&D update

April 10, 2014

Innate Pharma SA (the “Company” - Euronext Paris: FR0010331421 – IPH), the innate immunity company developing first-in-class drug candidates for cancer and inflammatory diseases, today holds an R&D...

Annual General Meeting of Shareholders | Marseille, France

March 27, 2014

ACTIONARIA 2013

November 22, 2013

Rendez-Vous des entreprises cotées à Marseille

March 6, 2014

Oddo Midcap Forum 2014

January 9, 2014

JP Morgan’s 32nd Annual Healthcare Conference

January 13, 2014

Credit Suisse Healthcare Conference 2014

March 4, 2014

Innate Pharma announces its financial calendar for 2014 as well as its participation to upcoming investor conferences

January 30, 2014

Innate Pharma SA (Euronext Paris: FR0010331421 – IPH) announces today its tentative financial calendar for 2014. In February and March 2014, Innate Pharma management will be present at the following...

Leerink Swann Global Healthcare Conference

February 12, 2014

Subscribe to Investor events

Company
Science
Products
- Pipeline overview
- ------------------
- Lacutamab
- IPH4502
- Monalizumab
- Other Clinical Stage Assets
  - IPH6501
  - IPH6101
  - IPH6401
  - IPH5201
  - IPH5301
Partnering
Investors
Media
Careers